Mammalian Cytosine DNA Methyltransferase Dnmt1: Enzymatic Mechanism, Novel Mechanism-Based Inhibitors, and RNA-directed DNA Methylation

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|1|92-106

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.1, 2008-01, pp. : 92-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

By Gore Steven D.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 83-90

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 379-399

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures

By  

Current Drug Metabolism, Vol. 17, Iss. 10, 2016-12 ,pp. : 971-991

Bentham Science Publishers

Access to resources Recommend Favorite

Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-04 ,pp. : 865-874

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Design of Mechanism-based and Alternate Substrate Inhibitors of Serine Proteases

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 12, 2004-08 ,pp. : 1203-1216

Bentham Science Publishers

Access to resources Recommend Favorite